AGAPE ATP CORPORATION Investment Income, Interest
AGAPE ATP CORPORATION (ATPC) reported Investment Income, Interest of $3.42 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- AGAPE ATP CORPORATION investment income, interest for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AGAPE ATP CORPORATION investment income, interest for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AGAPE ATP CORPORATION investment income, interest for the quarter ending 2025-06-30 was $153.00, a 99.21% decline year-over-year.
- AGAPE ATP CORPORATION investment income, interest for the quarter ending 2025-03-31 was $3.26K, a 85.69% decline year-over-year.
- AGAPE ATP CORPORATION investment income, interest for fiscal 2025 was $3.42K, a 94.97% decline from fiscal 2024.
- AGAPE ATP CORPORATION investment income, interest for fiscal 2024 was $67.93K, a 132.25% increase from fiscal 2023.
- AGAPE ATP CORPORATION investment income, interest for fiscal 2023 was $29.25K, a 80.66% increase from fiscal 2022.
- AGAPE ATP CORPORATION investment income, interest for fiscal 2022 was $16.19K, a 36.68% decline from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $0.00 derived: sum of 2 quarters · filed 2026-04-13 | $153.00 derived: sum of 3 quarters · filed 2026-08-14 | $3.42K 10-K · filed 2026-04-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $153.00 derived: sum of 2 quarters · filed 2026-08-14 | $3.42K 10-Q · filed 2025-11-13 | $12.91K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $153.00 10-Q · filed 2026-08-14 | $3.42K 10-Q · filed 2026-08-14 | $12.91K derived: sum of 3 quarters · filed 2026-08-14 | $29.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $3.26K 10-Q · filed 2026-05-15 | $12.76K derived: sum of 2 quarters · filed 2026-05-15 | $29.05K derived: sum of 3 quarters · filed 2026-05-15 | $48.38K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $9.50K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $25.79K derived: sum of 2 quarters · filed 2026-04-13 | $45.12K derived: sum of 3 quarters · filed 2026-04-13 | $67.93K 10-K · filed 2026-04-13 |
| 2024-09-30 | $16.29K 10-Q · filed 2025-11-13 | $35.62K derived: sum of 2 quarters · filed 2025-11-13 | $58.43K 10-Q · filed 2025-11-13 | $82.21K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $19.33K 10-Q · filed 2025-08-13 | $42.14K 10-Q · filed 2025-08-13 | $65.92K derived: sum of 3 quarters · filed 2025-08-13 | $66.57K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $22.81K 10-Q · filed 2025-05-15 | $46.58K derived: sum of 2 quarters · filed 2025-05-15 | $47.24K derived: sum of 3 quarters · filed 2025-05-15 | $48.88K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $23.77K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $24.43K derived: sum of 2 quarters · filed 2025-03-31 | $26.07K derived: sum of 3 quarters · filed 2025-03-31 | $29.25K 10-K · filed 2025-03-31 |
| 2023-09-30 | $658.00 10-Q · filed 2024-11-14 | $2.29K derived: sum of 2 quarters · filed 2024-11-14 | $5.47K 10-Q · filed 2024-11-14 | $9.59K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.63K 10-Q · filed 2024-08-14 | $4.82K 10-Q · filed 2024-08-14 | $8.94K derived: sum of 3 quarters · filed 2024-08-14 | $12.76K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $3.18K 10-Q · filed 2024-05-14 | $7.30K derived: sum of 2 quarters · filed 2024-05-14 | $11.12K derived: sum of 3 quarters · filed 2024-05-14 | $14.65K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $4.12K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $7.94K derived: sum of 2 quarters · filed 2024-04-01 | $11.46K derived: sum of 3 quarters · filed 2024-04-01 | $16.19K 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.82K 10-Q · filed 2023-11-14 | $7.35K derived: sum of 2 quarters · filed 2023-11-14 | $12.07K 10-Q · filed 2023-11-14 | $17.64K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $3.53K 10-Q · filed 2023-08-14 | $8.25K 10-Q · filed 2023-08-14 | $13.82K derived: sum of 3 quarters · filed 2023-08-14 | $19.65K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $4.72K 10-Q · filed 2023-05-15 | $10.30K derived: sum of 2 quarters · filed 2023-05-15 | $16.13K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $5.57K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $11.40K derived: sum of 2 quarters · filed 2023-03-31 | $25.57K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $5.83K 10-Q · filed 2022-11-14 | $20.00K 10-Q · filed 2022-11-14 | ||
| 2021-03-31 | $7.36K 10-Q · filed 2022-05-13 | |||
| 2020-03-31 | $18.13K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |